KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Operating Leases (2019 - 2025)

Historic Operating Leases for BeOne Medicines (ONC) over the last 7 years, with Q3 2025 value amounting to $51.4 million.

  • BeOne Medicines' Operating Leases rose 5833.8% to $51.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.4 million, marking a year-over-year increase of 5833.8%. This contributed to the annual value of $44.3 million for FY2024, which is 17.19% up from last year.
  • Latest data reveals that BeOne Medicines reported Operating Leases of $51.4 million as of Q3 2025, which was up 5833.8% from $53.9 million recorded in Q2 2025.
  • BeOne Medicines' 5-year Operating Leases high stood at $65.0 million for Q4 2021, and its period low was $17.7 million during Q1 2024.
  • Over the past 5 years, BeOne Medicines' median Operating Leases value was $37.6 million (recorded in 2021), while the average stood at $39.9 million.
  • As far as peak fluctuations go, BeOne Medicines' Operating Leases plummeted by 4554.28% in 2024, and later soared by 20975.62% in 2025.
  • Over the past 5 years, BeOne Medicines' Operating Leases (Quarter) stood at $65.0 million in 2021, then dropped by 9.86% to $58.6 million in 2022, then fell by 24.52% to $44.2 million in 2023, then grew by 0.17% to $44.3 million in 2024, then increased by 16.06% to $51.4 million in 2025.
  • Its Operating Leases stands at $51.4 million for Q3 2025, versus $53.9 million for Q2 2025 and $54.9 million for Q1 2025.